HOW TO CITE BQC19
Citing BQC19 correctly
The contribution of the BQC19 to any scientific production must be mentioned in the acknowledgments section of any scientific communication (oral presentation, poster, or journal article) that has used its data or samples. The following text may be added to the section:
This work was made possible thanks to the sharing of data and samples from the Quebec COVID-19 Biobank, funded by the Fonds de recherche du Québec-Santé, Génome Québec, the Public Health Agency of Canada, and the Ministère de la Santé et des Services sociaux. We thank all BQC19 participants for their valuable contribution.
In addition, the following article describing the BQC19 must be cited as a reference:
Tremblay K, Rousseau S, Zawati MH, Auld D, Chassé M, Coderre D, Falcone EL, Gauthier N, Grandvaux N, Gros-Louis F, Jabet C, Joly Y, Kaufmann DE, Laprise C, Larochelle C, Maltais F, Mes-Masson AM, Montpetit A, Piché A, Richards JB, Tse SM, Turgeon AF, Turecki G, Vinh DC, Wang HT, Mooser V; BQC19. The Quebec COVID-19 Biobank (BQC19)—A cohort to prospectively study the clinical and biological determinants of COVID-19 clinical trajectories. PLoS One. 2021 May 19;16(5):e0245031. doi: 10.1371/journal.pone.0245031. PMID: 34010280; PMCID: PMC8133500.
- The keyword BQC19 must be included in the list of keywords associated with the work.
- Scientific publications describing the methodology of certain datasets must be cited (see table).
- When using secondary data (i.e., data generated by researchers who used data or samples from BQC19), the original article describing these data must be cited. Researchers are encouraged to collaborate with the teams that generated the data to ensure optimal use and recognition of everyone's work.
| Data domains | Article | Contact |
|---|---|---|
| Proteomics #1 Somalogic | A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity Zhou S et al https://www.nature.com/articles/s41591-021-01281-1 Circulating proteins to predict adverse COVID-19 outcomes Su CY et al https://www.medrxiv.org/content/10.1101/2021.10.04.21264015v1 | brent.richards@mcgill.ca |
| Metabolomics Metabolon | Precision of a Clinical Metabolomics Profiling Platform for Use in the Identification of Inborn Errors of Metabolism Ford L et al https://academic.oup.com/jalm/article/5/2/342/5741398 | dtoal@metabolon.com |
| Immuno-sérologie #1 Laboratoire d'Andrès Finzi | Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals https://pubmed.ncbi.nlm.nih.gov/33067385/ Beaudouin-Bussières G et al Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset Anand SP et al https://pubmed.ncbi.nlm.nih.gov/33969322/ | andres.finzi@umontreal.ca |
| Immunoserology #2 NML Laboratory | Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization Assays Valcourt E et al https://journals.asm.org/doi/10.1128/Spectrum.00886-21 | heidi.wood@canada.ca |